| Metric | შპს ნეოფარმი + | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾16.3m₾13.9m | ₾2.70bn₾2.32bn |
| Revenue growth | 17.4% | 16.6% |
| Profitability | ||
| EBITDA | -₾836k-₾1.3m | — |
| EBITDA margin | -5.1%-9.0% | — |
| Net profit | -₾873k-₾1.3m | ₾1.84bn₾1.33bn |
| Net margin | -5.4%-9.1% | 68.1%57.6% |
| Balance sheet | ||
| Total assets | ₾5.7m₾6.3m | ₾39.27bn₾31.39bn |
| Total equity | ₾14k₾887k | ₾5.63bn₾4.45bn |
| ROE | -6150.6%-142.2% | 32.6%30.0% |